Charles River Laboratories International, Inc.

R$822.96
BRL
Last updated on --.
24h volume131.74K
24h highest830.21 BRL
24h lowest794.60 BRL
24h Price movement+3.57%

CRL recent prices

24 Hours
+3.57%+R$28.34
30 days
-8.98%-R$78.00
60 days
+0.21%+R$1.723
90 days
-11.18%-R$99.44

Key data

Previous close794.62 BRL
Market cap38.10B BRL
Volume131.74K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-19.4181 BRL
Net income (FY)-927.01M BRL
Revenue (FY)20.42B BRL
Last report date7 May 2026

About Charles River Laboratories International, Inc.

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
HeadquartersWILMINGTON
Employees (FY)19.70K
Revenue per employee (FY)1.04M BRL
Net income per employee (FY)-47.06K BRL
Listed onNew York Stock Exchange
Official website

CRL conversion tables

CRLCRL
BRLBRL
0.5 CRL411.48 BRL
1 CRL822.96 BRL
5 CRL4,114.81 BRL
10 CRL8,229.62 BRL
BRLBRL
CRLCRL
0.5 BRL0.00060756 CRL
1 BRL0.0012151 CRL
5 BRL0.0060756 CRL
10 BRL0.012151 CRL

FAQ

CRL is trading at R$822.96, +3.57% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CRL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CRL is currently trading at R$822.96, +3.57% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CRL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CRL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CRL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CRL's historical range and other companies in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.
Charles River Laboratories International, Inc.'s market cap is currently 38.10B BRL. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume131.74K
24h highest830.21 BRL
24h lowest794.60 BRL
24h Price movement+3.57%
CRLCRL
BRLBRL
Start trade with CRL Perpetual